These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17042086)

  • 1. [Very good effect of Hib vaccination in Kenya].
    Gjersvik P
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2554. PubMed ID: 17042086
    [No Abstract]   [Full Text] [Related]  

  • 2. Global use of Haemophilus influenzae type b conjugate vaccine.
    Ojo LR; O'Loughlin RE; Cohen AL; Loo JD; Edmond KM; Shetty SS; Bear AP; Privor-Dumm L; Griffiths UK; Hajjeh R
    Vaccine; 2010 Oct; 28(43):7117-22. PubMed ID: 20691265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries--worldwide, 2004-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):148-51. PubMed ID: 18272957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward global Haemophilus influenzae type b immunization.
    Dominguez SR; Daum RS
    Clin Infect Dis; 2003 Dec; 37(12):1600-2. PubMed ID: 14689338
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda.
    Muganga N; Uwimana J; Fidele N; Gahimbare L; Gessner BD; Mueller JE; Mhlanga BR; Katsande R; Herbinger KH; Rugambwa C
    Vaccine; 2007 Sep; 25(39-40):7001-5. PubMed ID: 17709159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease.
    Cartwright KA; Begg NT; Rudd PT
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R16-7. PubMed ID: 7511459
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(11):234-7. PubMed ID: 11925021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemophilus influenzae infection and their prevention by vaccination].
    Scholz H; Noack R
    Kinderarztl Prax; 1993 Aug; 61(6):189-91. PubMed ID: 8411843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
    Gessner BD; Adegbola RA
    Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias.
    Shapiro ED
    Pediatr Infect Dis J; 2004 Feb; 23(2):127-31. PubMed ID: 14872178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of functional Haemophilus influenzae type b antibodies after vaccination.
    van der Velden AM; Claessen AM; van Velzen-Blad H; Biesma DH; Rijker GT
    Haematologica; 2005 Nov; 90(11):1582-4. PubMed ID: 16266910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hib vaccination controversy and the declaration of commercial interest.
    Taneja V
    Indian Pediatr; 2003 Jan; 40(1):75-6. PubMed ID: 12554930
    [No Abstract]   [Full Text] [Related]  

  • 13. The launch of an infant Haemophilus influenzae type B immunization programme in Iceland.
    Olafsson O; Jónsdóttir KE; Barreto L; Hansen H; Sigthorsson T
    Arctic Med Res; 1991; Suppl():341-3. PubMed ID: 1365148
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
    Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
    Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hib immunisation catch up programme in North East Thames.
    O'Brien H
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R17-8. PubMed ID: 7511460
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haemophilus influenzae meningitis in a child with complete immunisation].
    Zjevíková A; Roznovský L; Krízová P; Lebedová V
    Klin Mikrobiol Infekc Lek; 2004 Feb; 10(1):22-4. PubMed ID: 15100979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunisation against Haemophilus influenzae type b.
    Levy M; Menzies R
    Aust J Public Health; 1995 Feb; 19(1):108. PubMed ID: 7734585
    [No Abstract]   [Full Text] [Related]  

  • 19. Lest we forget acute epiglottitis.
    Selvadurai H; McIntyre P; Mellis C
    J Paediatr Child Health; 1998 Jun; 34(3):306-7. PubMed ID: 9633988
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidenced-based decision making about Hib vaccination.
    Mitchell V; Walker D; Zuber P; Lydon P; Ahun M;
    Lancet; 2005 Mar 12-18; 365(9463):936-7. PubMed ID: 15766989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.